Comparison of Two Different Techniques for Isolated Left Subclavian Artery Revascularization During Thoracic Endovascular Aortic Repair in Zone 2

医学 主动脉修补术 血运重建 左锁骨下动脉 心脏病学 锁骨下动脉 外科 内科学 冲程(发动机) 主动脉 主动脉弓 心肌梗塞 机械工程 工程类
作者
Gabriele Piffaretti,Giovanni Pratesi,Guido Gelpi,Mario Galli,Frank J. Criado,Michele Antonello
出处
期刊:Journal of Endovascular Therapy [SAGE]
卷期号:25 (6): 740-749 被引量:27
标识
DOI:10.1177/1526602818802581
摘要

To analyze the results of isolated left subclavian artery (LSA) revascularization during thoracic endovascular aortic repair (TEVAR) using carotid-subclavian bypass (CSbp) or chimney grafts (CGs).A retrospective multicenter, observational study identified 73 patients (mean age 68±13 years, range 22-87; 56 men) with acute or chronic thoracic aortic lesions who underwent TEVAR with isolated LSA revascularization using either CSbp (n=42) or CGs (n=31) from January 2010 and February 2017. Primary endpoints were TEVAR-related mortality, postoperative stroke, freedom from type Ia endoleak, and LSA patency.Primary technical success was achieved in all cases. Early TEVAR-related mortality was 4.2% (CSbp 2% vs CG 6%, p=0.571). Two (3%) patients had major ischemic strokes (one in each group). Mean follow-up was 24±21 months (range 1-72; median 15). Estimated freedom from TEVAR-related mortality was 93%±3% (95% CI 84.3% to 97.0%) at 12 and 36 months, with no significant difference between CSbp and CG (p=0.258). Aortic reintervention did not differ between the groups (CSbp 5% vs CG 6%, p=0.356); nor did freedom from type Ia endoleak (CSbp 98% vs CG 87%, p=0.134). Gutter-related endoleaks occurred in 4 (13%) CG patients, but none of the patients experienced sac enlargement or the need for reintervention and none died. Primary patency of the LSA was 100% for the entire group during the observation period.In our experience, LSA revascularization proved most satisfactory and equally effective with both the CSbp and CG techniques, without discernible differences at midterm follow-up.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
秋老虎发布了新的文献求助10
刚刚
姝飞糊涂发布了新的文献求助10
1秒前
1秒前
qiqigao发布了新的文献求助10
2秒前
2秒前
汉堡包应助小白生信采纳,获得10
3秒前
3秒前
4秒前
阳阳发布了新的文献求助10
5秒前
懒懒洋洋洋完成签到 ,获得积分10
5秒前
哈哈哈发布了新的文献求助10
6秒前
qaw发布了新的文献求助10
7秒前
咕咕完成签到,获得积分10
7秒前
7秒前
8秒前
8秒前
9秒前
阳光的羊完成签到,获得积分10
9秒前
9秒前
10秒前
FashionBoy应助DSH采纳,获得10
10秒前
魁梧的盼夏完成签到,获得积分10
11秒前
xy完成签到,获得积分10
11秒前
咕咕发布了新的文献求助10
11秒前
123发布了新的文献求助10
13秒前
阳光的羊发布了新的文献求助10
14秒前
林贞宝宝发布了新的文献求助10
15秒前
DL发布了新的文献求助10
15秒前
15秒前
希望天下0贩的0应助123采纳,获得10
18秒前
深情安青应助卡尔采纳,获得10
19秒前
20秒前
qaw发布了新的文献求助10
20秒前
21秒前
21秒前
崔风机应助Bellamie采纳,获得10
21秒前
manan发布了新的文献求助10
22秒前
爱科研的琪琪完成签到,获得积分10
23秒前
L外驴尔X发布了新的文献求助10
23秒前
24秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Aspects of Babylonian celestial divination : the lunar eclipse tablets of enuma anu enlil 1500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3459542
求助须知:如何正确求助?哪些是违规求助? 3053895
关于积分的说明 9039379
捐赠科研通 2743266
什么是DOI,文献DOI怎么找? 1504749
科研通“疑难数据库(出版商)”最低求助积分说明 695392
邀请新用户注册赠送积分活动 694685